what drug company makes semaglutide Novo Nordisk bets on Wegovy pill to win weight loss battle beyond U.S Semaglutide: The benefits and risks

Semaglutide is an FDA-approved medication designed to support weight loss by reducing appetite and enhancing feelings of fullness

In terms of long-term use, both Semaglutide and Tirzepatide have been FDA-approved for chronic weight management: Semaglutide under the brand Wegovy and Tirzepatide under the brand Zepbound

Benefits Boosts energy levels by supporting your bodys natural cellular energy production

Patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) are also absolutely contraindicated from receiving semaglutide

Norepinephrine is a neurotransmitter that plays a role in regulating appetite, metabolism, and energy expenditure